Sharechat Logo

Babcock & Brown stock halted pending response from banks

Thursday 8th January 2009

Text too small?
Babcock & Brown, the Australian investment group whose shares have lost almost 100% of their value the past 12 months, was halted from trading pending a decision from its banks on a rescue plan.

The company wants to buy enough time to sell assets to repay debt and prevent collapse. Yesterday it said impairment charges mean liabilities "substantially" outweigh assets.

"The group's banking syndicate has indicated that it will be providing later today a partial response to the proposal," it said in a statement. "The trading halt will end upon the syndicate providing a complete response which we expect to occur before the opening of the market" on January 12, it said.

Shares of the firm's infrastructure and energy units, which trade separately on the ASX, tumbled today. Babcock & Brown Infrastructure dropped 14% to 12 cents and Babcock & Brown Power fell 13% to 10.5 cents amid concern their finances would suffer if the parent fails.

The five largest banks in Australia have about A$700 million in loans to Babcock & Brown and overseas banks are owed as much as A$2 billion, according to analysts.

The company is trying to avoid the fate of Allco Finance Group, a manager of funds that collapsed last year.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors